Provided by Tiger Trade Technology Pte. Ltd.

Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)

4.73
-0.2500-5.02%
Post-market: 4.58-0.1500-3.17%16:56 EST
Volume:113.41K
Turnover:536.69K
Market Cap:194.86M
PE:-1.85
High:5.07
Open:4.99
Low:4.53
Close:4.98
52wk High:8.79
52wk Low:2.34
Shares:41.20M
Float Shares:30.36M
Volume Ratio:0.59
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5606
EPS(LYR):-3.7669
ROE:-2698.53%
ROA:-268.96%
PB:52.69
PE(LYR):-1.26

Loading ...

Stephen Denaro Resigns from Anteris Technologies Global Corp. Board

Reuters
·
Yesterday

Anteris Technologies Global Corp-Board Resignation

THOMSON REUTERS
·
Yesterday

Board Resignation-AVR.O

Reuters
·
Yesterday

Change of Director's Interest Notice-AVR.O

Reuters
·
Dec 11

Notification regarding unquoted securities - AVR-AVR.O

Reuters
·
Dec 11

Statement of CDIs on issue - AVR-AVR.O

Reuters
·
Dec 05

Results of Meeting-AVR.O

Reuters
·
Dec 04

Anteris Technologies Global Corp-Annual Meeting CEO Presentation

THOMSON REUTERS
·
Dec 04

Notification of cessation of securities - AVR-AVR.O

Reuters
·
Dec 03

Anteris Technologies Global Corp - Not Renewing Agreement With 4C Medical - SEC Filing

THOMSON REUTERS
·
Dec 02

Anteris Technologies Global Corp - No Early Termination Penalties for Non-Renewal - SEC Filing

THOMSON REUTERS
·
Dec 02

BRIEF-Anteris Technologies Global To Offer Up To 9.1 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing

Reuters
·
Nov 27

Anteris Technologies Global Corp - to Offer up to 9.1 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Nov 27

Anteris Technologies Global Corp Says FDA Approves Duravr THV Global Pivotal Trial

Reuters
·
Nov 20

Anteris Technologies Reports Positive 30-Day Results for DurAVR THV in Severe Aortic Stenosis Trial

Reuters
·
Nov 17

AVR Presents Data from 100 DurAVR THV Patients-AVR.O

Reuters
·
Nov 17

Anteris Technologies Glb Q3 EPS $(0.62) Misses $(0.57) Estimate, Sales $429.000K Beat $400.000K Estimate

Benzinga
·
Nov 13

Anteris Technologies posts $16.8 million R&D expenses and $5.8 million SG&A expenses in Q3 2025

Reuters
·
Nov 13

Press Release: Anteris Announces Results for the Third Quarter of 2025

Dow Jones
·
Nov 13

Anteris Technologies Global Corp-Quarterly Results Announcement and SEC Form 10-Q

THOMSON REUTERS
·
Nov 13